DOK2 Inhibits EGFR-Mutated Lung Adenocarcinoma

• Alice H. Berger,

  Current address: Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, United States of America; Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America

  Affiliation Cancer Genetics Program, Beth Israel Deaconess Cancer Center, Departments of Medicine and Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Ming Chen,

  Affiliation Cancer Genetics Program, Beth Israel Deaconess Cancer Center, Departments of Medicine and Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Alessandro Morotti,

  Affiliation Cancer Genetics Program, Beth Israel Deaconess Cancer Center, Departments of Medicine and Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Justyna A. Janas,

  Affiliation Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, United States of America

  ⨯
• Masaru Niki,

  Affiliation Department of Internal Medicine, University of Iowa, Iowa City, Iowa, United States of America

  ⨯
• Roderick T. Bronson,

  Affiliation Rodent Histopathology Core, Dana-Farber/Harvard Cancer Center, Boston, Massachusetts, United States of America

  ⨯
• Barry S. Taylor,

  Current address: Departments of Epidemiology and Biostatistics, Medicine, and the Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California, United States of America

  Affiliation Computational Biology Center, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America

  ⨯
• Marc Ladanyi,

  Affiliations Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America, Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America

  ⨯
• Linda Van Aelst,

  Affiliation Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, United States of America

  ⨯
• Katerina Politi,

  Current address: Department of Pathology and Yale Cancer Center, Yale University School of Medicine, New Haven, Connecticut, United States of America

  Affiliation Cancer Biology and Genetics Program, Sloan-Kettering Institute, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America

  ⨯
• Harold E. Varmus,

  Current address: National Cancer Institute, Bethesda, Maryland, United States of America

  Affiliation Cancer Biology and Genetics Program, Sloan-Kettering Institute, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America

  ⨯
• Pier Paolo Pandolfi

  * E-mail: ppandolf@bidmc.harvard.edu

  Affiliation Cancer Genetics Program, Beth Israel Deaconess Cancer Center, Departments of Medicine and Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯